Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0459 | 0.0425 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.1056 | 0.1056 |
Brugia malayi | hypothetical protein | 0.0039 | 0.177 | 0.1652 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0088 | 0.516 | 0.5143 |
Echinococcus multilocularis | muscleblind protein | 0.0158 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0025 | 0.0794 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0088 | 0.516 | 0.589 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1056 | 0.1056 |
Mycobacterium leprae | conserved hypothetical protein | 0.0025 | 0.0794 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.102 | 0.102 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.1056 | 0.1023 |
Echinococcus multilocularis | lamin | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.1056 | 0.0747 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.8441 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0459 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0459 | 0.0323 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0747 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0459 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.177 | 1 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.1056 | 0.0928 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0459 | 0.5 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0141 | 0.0141 |
Entamoeba histolytica | hypothetical protein | 0.0025 | 0.0794 | 0.2552 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.8441 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 0.177 | 0.174 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0025 | 0.0794 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0025 | 0.0794 | 1 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0025 | 0.0794 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0025 | 0.0794 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 0.177 | 0.174 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0747 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0135 | 0.8441 | 0.8419 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 0.177 | 0.1642 |
Echinococcus multilocularis | musashi | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.8441 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.177 | 1 |
Onchocerca volvulus | 0.0088 | 0.516 | 1 | |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0025 | 0.0794 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.1056 | 0.1056 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0025 | 0.0794 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0459 | 0.0459 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0459 | 0.5 |
Echinococcus granulosus | muscleblind protein | 0.0158 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0135 | 0.8441 | 0.8441 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0459 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.516 | 0.516 |
Echinococcus granulosus | lamin | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.8441 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0135 | 0.8441 | 0.8435 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0158 | 1 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0025 | 0.0794 | 1 |
Brugia malayi | RNA binding protein | 0.0135 | 0.8441 | 0.8419 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0036 | 0.0036 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0025 | 0.0794 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0135 | 0.8441 | 0.8441 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0025 | 0.0794 | 1 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0025 | 0.0794 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0088 | 0.516 | 0.5143 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.177 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0025 | 0.0794 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.8441 | 1 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0088 | 0.516 | 0.5091 |
Brugia malayi | TAR-binding protein | 0.0135 | 0.8441 | 0.8419 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.177 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0135 | 0.8441 | 0.8435 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.177 | 0.1642 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0459 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.1056 | 0.0928 |
Loa Loa (eye worm) | TAR-binding protein | 0.0135 | 0.8441 | 0.8441 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.